Evaluation of the therapeutic potential and underlying mechanisms of synephrine, a component of Kampo medicine, against allergic rhinitis

The mechanisms of action of Kampo medicines as treatments for allergic rhinitis are unknown. In this study, we aimed to identify novel potential therapeutic agents for allergic rhinitis and to elucidate their underlying mechanisms. Different components of Kampo medicines (crude drugs) were screened...

Full description

Saved in:
Bibliographic Details
Published inCogent biology Vol. 5; no. 1; p. 1592274
Main Authors Hommura, Tomoko, Dan, Katsuaki, Kanzaki, Sho, Watanabe, Kenji, Ogawa, Kaoru
Format Journal Article
LanguageEnglish
Published Abingdon Cogent 01.01.2019
Taylor & Francis Ltd
Subjects
Allergens
Allergic rhinitis
Epithelial cells
Gene expression
Histamine
histamine H1 receptor
Histamine H1 receptors
Histidine
Histidine decarboxylase
Hypersensitivity
Kampo
leukotriene antagonist
Mucin
Nose
synephrine
Thymic stromal lymphopoietin
Thymus
Western blotting
Online AccessGet full text

Cover

Abstract The mechanisms of action of Kampo medicines as treatments for allergic rhinitis are unknown. In this study, we aimed to identify novel potential therapeutic agents for allergic rhinitis and to elucidate their underlying mechanisms. Different components of Kampo medicines (crude drugs) were screened for their ability to inhibit the secretion of thymic stromal lymphopoietin (TSLP), a cytokine secreted during allergen exposure. Synephrine (SYN) exhibited the strongest inhibitory effect. In an early-phase allergic reaction, histidine decarboxylase (HDC) and its receptor are activated, leading to the secretion of TSLP. Mucins are thought to be produced as a late-phase reaction. We examined the action of SYN in cultures of human nasal epithelial cells both during mono-stimulation and co-stimulation with activating agents. Based on its inhibition of the histamine H1 receptor and HDC mRNA expression, SYN was assumed to reduce the histamine production. Increased expression of the HDC protein was confirmed in tissues of patients with allergic rhinitis via western blotting. In addition, SYN inhibited TSLP at the mRNA and protein levels and inhibited mucin 5AC mRNA expression. Its inhibitory effects on both early- and late-phase allergic reactions indicate that SYN can serve as a novel therapeutic agent with potential leukotriene antagonist-like activity.
AbstractList The mechanisms of action of Kampo medicines as treatments for allergic rhinitis are unknown. In this study, we aimed to identify novel potential therapeutic agents for allergic rhinitis and to elucidate their underlying mechanisms. Different components of Kampo medicines (crude drugs) were screened for their ability to inhibit the secretion of thymic stromal lymphopoietin (TSLP), a cytokine secreted during allergen exposure. Synephrine (SYN) exhibited the strongest inhibitory effect. In an early-phase allergic reaction, histidine decarboxylase (HDC) and its receptor are activated, leading to the secretion of TSLP. Mucins are thought to be produced as a late-phase reaction. We examined the action of SYN in cultures of human nasal epithelial cells both during mono-stimulation and co-stimulation with activating agents. Based on its inhibition of the histamine H1 receptor and HDC mRNA expression, SYN was assumed to reduce the histamine production. Increased expression of the HDC protein was confirmed in tissues of patients with allergic rhinitis via western blotting. In addition, SYN inhibited TSLP at the mRNA and protein levels and inhibited mucin 5AC mRNA expression. Its inhibitory effects on both early- and late-phase allergic reactions indicate that SYN can serve as a novel therapeutic agent with potential leukotriene antagonist-like activity.
Author Ogawa, Kaoru
Watanabe, Kenji
Hommura, Tomoko
Dan, Katsuaki
Kanzaki, Sho
Author_xml – sequence: 1
  givenname: Tomoko
  surname: Hommura
  fullname: Hommura, Tomoko
  email: tomokohommura@keio.jp
  organization: Keio University School of Medicine
– sequence: 2
  givenname: Katsuaki
  surname: Dan
  fullname: Dan, Katsuaki
  organization: Research Organization of Biological Activity
– sequence: 3
  givenname: Sho
  surname: Kanzaki
  fullname: Kanzaki, Sho
  organization: Keio University School of Medicine
– sequence: 4
  givenname: Kenji
  surname: Watanabe
  fullname: Watanabe, Kenji
  organization: Keio University
– sequence: 5
  givenname: Kaoru
  surname: Ogawa
  fullname: Ogawa, Kaoru
  organization: Keio University School of Medicine
BookMark eNp9kMFq3DAQhkVJIdskjxAQ9FpvNKMoXt9aQtKGBHJJz2JsSbtabMmV5JZ9hLx1bTaFnnIQ0uj__5nh-8ROQgyWsUsQaxAbcYVSAgpUaxTQrEE1iPX1B7Za_qtFOPnvfcouct4LIUDdIIJasde739RPVHwMPDpednY5iUY7Fd_xMRYbiqeeUzB8Csam_uDDlg-221HwechLLB-CHXfJB_uFE-_iMM5LhrJIjzQXs9347ihvyYdcOPW9Tdt5RNr54IvP5-yjoz7bi7f7jP28v3u5_VE9PX9_uP32VHUSVKkQEG2rlAOzkWAkCDRNU0u4brF1pna2bswMQVjRWFHTplWICjpybWuQUJ6xz8e-Y4q_JpuL3scphXmkRqlAKLhRm9mljq4uxZyTdXpMfqB00CD0Al7_A68X8PoN_Jz7esz54GIa6E9MvdGFDn1MLlHofNby_RZ_AaeFjZw
CitedBy_id crossref_primary_10_1016_j_jconrel_2021_05_048
Cites_doi 10.1164/ajrccm.163.2.2004039
10.1177/000348940411300707
10.1097/MLG.0b013e3180383651
10.3390/molecules190811211
10.1007/PL00007616
10.1159/000346609
10.1248/yakushi1947.109.11_835
10.2500/ajra.2016.30.4295
10.1067/mai.2003.1512
10.1113/jphysiol.1910.sp001406
10.1164/ajrccm.161.6.9909098
10.1517/14728222.12.4.415
10.1155/2017/5974574
10.1186/1465-9921-6-100
10.1016/j.ejphar.2003.12.038
10.4049/jimmunol.179.2.1080
10.1097/ACI.0b013e32831d815c
10.1046/j.1365-2222.2001.01045.x
10.1093/intimm/dxv055
10.5631/jibirin.88.389
10.1016/j.phrs.2016.08.001
10.1177/019459989010300406
10.1016/j.alit.2014.11.002
10.1007/BF02484434
ContentType Journal Article
Copyright 2019 The Author(s). This open access article is distributed under a Creative Commons Attribution (CC-BY) 4.0 license. 2019
2019 The Author(s). This open access article is distributed under a Creative Commons Attribution (CC-BY) 4.0 license. This work is licensed under the Creative Commons Attribution License http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright_xml – notice: 2019 The Author(s). This open access article is distributed under a Creative Commons Attribution (CC-BY) 4.0 license. 2019
– notice: 2019 The Author(s). This open access article is distributed under a Creative Commons Attribution (CC-BY) 4.0 license. This work is licensed under the Creative Commons Attribution License http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
DBID 0YH
AAYXX
CITATION
8FE
8FH
ABUWG
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
CCPQU
DWQXO
GNUQQ
HCIFZ
LK8
M7P
PIMPY
PQEST
PQQKQ
PQUKI
DOI 10.1080/23312025.2019.1592274
DatabaseName Taylor & Francis Open Access
CrossRef
ProQuest SciTech Collection
ProQuest Natural Science Collection
ProQuest Central (Alumni Edition)
ProQuest Central
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
Natural Science Collection
ProQuest One Community College
ProQuest Central Korea
ProQuest Central Student
SciTech Premium Collection
ProQuest Biological Science Collection
Biological Science Database
Publicly Available Content Database
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
DatabaseTitle CrossRef
Publicly Available Content Database
ProQuest Central Student
ProQuest Biological Science Collection
ProQuest Central Essentials
ProQuest One Academic Eastern Edition
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest Natural Science Collection
Biological Science Database
ProQuest SciTech Collection
ProQuest Central
ProQuest One Academic UKI Edition
Natural Science Collection
ProQuest Central Korea
Biological Science Collection
ProQuest One Academic
DatabaseTitleList Publicly Available Content Database
Database_xml – sequence: 1
  dbid: 0YH
  name: Taylor & Francis Open Access
  url: https://www.tandfonline.com
  sourceTypes: Publisher
– sequence: 2
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 2331-2025
Editor Hsu, Tsai-Ching
Editor_xml – sequence: 1
  givenname: Tsai-Ching
  surname: Hsu
  fullname: Hsu, Tsai-Ching
  organization: Chung Shan Medical University, Taiwan, province of china
ExternalDocumentID 10_1080_23312025_2019_1592274
1592274
Genre Research Article
GroupedDBID 0YH
5VS
8FE
8FH
AAWJR
ABDBF
ADBBV
ADCVX
AFKRA
ALMA_UNASSIGNED_HOLDINGS
BBNVY
BCNDV
BENPR
BHPHI
EAP
EBS
ESX
GROUPED_DOAJ
H13
HCIFZ
KQ8
LK8
M4Z
M7P
M~E
OK1
PIMPY
PROAC
TFMNY
TFW
AAYXX
CCPQU
CITATION
TDBHL
ABUWG
AZQEC
DWQXO
GNUQQ
PQEST
PQQKQ
PQUKI
ID FETCH-LOGICAL-c315t-2122eb55f1d831d3102d997314b2bfd7fe79d9220e09e07a8b52251cafbbd2a23
IEDL.DBID BENPR
ISSN 2331-2025
IngestDate Thu Oct 10 21:55:11 EDT 2024
Fri Aug 23 02:46:40 EDT 2024
Tue Jun 13 19:51:46 EDT 2023
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Language English
License open-access: http://creativecommons.org/licenses/by/4.0/: You are free to: Share - copy and redistribute the material in any medium or format. Adapt - remix, transform, and build upon the material for any purpose, even commercially. The licensor cannot revoke these freedoms as long as you follow the license terms. Under the following terms: Attribution - You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use. No additional restrictions You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c315t-2122eb55f1d831d3102d997314b2bfd7fe79d9220e09e07a8b52251cafbbd2a23
OpenAccessLink https://www.proquest.com/docview/2351051658?pq-origsite=%requestingapplication%
PQID 2351051658
PQPubID 2043298
ParticipantIDs informaworld_taylorfrancis_310_1080_23312025_2019_1592274
crossref_primary_10_1080_23312025_2019_1592274
proquest_journals_2351051658
PublicationCentury 2000
PublicationDate 20190101
PublicationDateYYYYMMDD 2019-01-01
PublicationDate_xml – month: 01
  year: 2019
  text: 20190101
  day: 01
PublicationDecade 2010
PublicationPlace Abingdon
PublicationPlace_xml – name: Abingdon
PublicationTitle Cogent biology
PublicationYear 2019
Publisher Cogent
Taylor & Francis Ltd
Publisher_xml – name: Cogent
– name: Taylor & Francis Ltd
References cit0011
cit0022
cit0012
cit0023
cit0020
cit0010
cit0021
Akasaki S. (cit0001) 2016; 28
cit0008
cit0019
cit0009
cit0006
cit0017
cit0007
cit0018
cit0004
cit0015
cit0005
cit0016
cit0002
cit0013
cit0024
cit0003
cit0014
References_xml – ident: cit0014
  doi: 10.1164/ajrccm.163.2.2004039
– ident: cit0013
  doi: 10.1177/000348940411300707
– ident: cit0003
  doi: 10.1097/MLG.0b013e3180383651
– ident: cit0016
  doi: 10.3390/molecules190811211
– ident: cit0024
  doi: 10.1007/PL00007616
– ident: cit0018
  doi: 10.1159/000346609
– ident: cit0011
  doi: 10.1248/yakushi1947.109.11_835
– ident: cit0012
  doi: 10.2500/ajra.2016.30.4295
– ident: cit0020
  doi: 10.1067/mai.2003.1512
– ident: cit0007
  doi: 10.1113/jphysiol.1910.sp001406
– ident: cit0019
  doi: 10.1164/ajrccm.161.6.9909098
– ident: cit0021
  doi: 10.1517/14728222.12.4.415
– ident: cit0023
  doi: 10.1155/2017/5974574
– ident: cit0008
  doi: 10.1186/1465-9921-6-100
– ident: cit0009
  doi: 10.1016/j.ejphar.2003.12.038
– ident: cit0010
  doi: 10.4049/jimmunol.179.2.1080
– ident: cit0002
  doi: 10.1097/ACI.0b013e32831d815c
– ident: cit0006
  doi: 10.1046/j.1365-2222.2001.01045.x
– volume: 28
  start-page: 65
  issue: 2
  year: 2016
  ident: cit0001
  publication-title: International Immunology
  doi: 10.1093/intimm/dxv055
  contributor:
    fullname: Akasaki S.
– ident: cit0004
  doi: 10.5631/jibirin.88.389
– ident: cit0017
  doi: 10.1016/j.phrs.2016.08.001
– ident: cit0015
  doi: 10.1177/019459989010300406
– ident: cit0022
  doi: 10.1016/j.alit.2014.11.002
– ident: cit0005
  doi: 10.1007/BF02484434
SSID ssj0001562215
Score 2.123521
Snippet The mechanisms of action of Kampo medicines as treatments for allergic rhinitis are unknown. In this study, we aimed to identify novel potential therapeutic...
SourceID proquest
crossref
informaworld
SourceType Aggregation Database
Publisher
StartPage 1592274
SubjectTerms Allergens
Allergic rhinitis
Epithelial cells
Gene expression
Histamine
histamine H1 receptor
Histamine H1 receptors
Histidine
Histidine decarboxylase
Hypersensitivity
Kampo
leukotriene antagonist
Mucin
Nose
synephrine
Thymic stromal lymphopoietin
Thymus
Western blotting
SummonAdditionalLinks – databaseName: Taylor & Francis Open Access
  dbid: 0YH
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LSwMxEA5aEbyIT6xWycGjWzfJptscRVqKgicLelqSTaIFuy3d9dCf4L92Zh_aIuLBY8hO2M1sMl8m38wQcmmtlJo5GSgb6iDSygZKpzIwJuqnkTOYnxDZFg-90Ti6e5INmzCvaZV4hvZVoohyr8bFrU3eMOKuuRAMzuwSiVmqC_aYw9Fqk2zxWJY3teHz6NvNAvYdrFoTu_Ob9JpVWstZ-mOPLg3PcI_s1oiR3lQq3icbLjsg21UNyeUh-Rh85eumM08Bz9GVmCo6nxXIB4IB4HMpRowt3jCyiU4dxvxO8mmOYvkyc6BWmIsrqinyzGcZyGHXvYYGbe7goftFTwBTUizCsoB9ky5eJ8hAyo_IeDh4vB0FdX2FIBVMFgFYLe6MlJ7ZvmAWgB63CktZRYYbb2PvYmVhekIXKhfGum8ArEmWam-M5ZqLY9LK4G1OCI1FqnhPCZ9qG8Uq1jYNtWM6tMZLIX2bdJv5TeZVGo2E1dlJG4UkqJCkVkibqFUtJEXpv_BVsZFE_CHbaVSW1CsyhycRSjIAXKf_GPqM7GCz8sF0SKtYvLtzQCWFuSj_u09bvNvA
  priority: 102
  providerName: Taylor & Francis
Title Evaluation of the therapeutic potential and underlying mechanisms of synephrine, a component of Kampo medicine, against allergic rhinitis
URI https://www.tandfonline.com/doi/abs/10.1080/23312025.2019.1592274
https://www.proquest.com/docview/2351051658
Volume 5
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV1RT9swED6NVki8IGAgGKzyA48LxHZM6qeJQqtqk9A0DQmeIju2t0qQdk144Cfwr3fXOAOEtD1Glq3In3P3-XJ3H8Cxc0oZ7lWiXWqSzGiXaFOqxNpsWGbeUn9Cyra4OpteZ19u1E0MuNUxrbKziStD7eYlxchPhSQqwNFhfl78Tkg1iv6uRgmNNegLvCmIHvRH46tv35-jLOje0al1pTvDFNeRHC_8irK69Ak6cyHy7JVTetWy9I2JXvmdyRZsRsLIzluEt-Gdr3ZgvZWQfHwPT-O_7brZPDCkc-xFSRVbzBtKB8IFTOUYFYwt76iwid17Kvmd1fc1TasfK4-oIuP8xAyjNPN5hfNo6KvBB9b9gsfhn2aGlJKRBssSzSZb_ppRAlK9C9eT8Y-LaRLlFZJSctUk6LSEt0oF7oaSO-R5wmlSssqssMHlwefa4fakPtU-zc3QIldTvDTBWieMkHvQq_Bt9oHlstTiTMtQGpflOjeuTI3nJnU2KKnCAZx0-1ss2i4aBY_NSTtACgKkiIAcgH6JQtGswheh1Rop5H_mHnWQFfGDrIvn4_Ph38OHsEGLtVGWI-g1ywf_EXlHYwewlt5OB9A_H12OJoN41P4A_7vaKA
link.rule.ids 315,783,787,21402,27516,27938,27939,33758,43819,59477,59478
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV1bT9swFLYGCMELYlw0Lht-4HGB2I6b-mnapqJCoUITSLxZdmyzSpCWJnvoT9i_3jmNQ0FI7DGybEX-nPN9OT4XQo6dk9IwLxPlUpNkRrlEmUIm1mbdIvMW6xNitMWw07_NLu7kXXS4VTGssrWJc0PtxgX6yE-5QCnAgDC_TZ4S7BqFt6uxhcYSWcFSVXCqV370hte_Fl4WoHcgtTZ1p5vCOoLBD7_EqC51AmTOeZ69IqVXJUvfmOg575xtko0oGOn3BuGP5IMvt8hq00Jytk3-9p7LddNxoCDn6IuUKjoZ1xgOBAuY0lFMGJs-YGITffSY8juqHiucVs1KD6iC4vxKDcUw83EJ83BoYOCBtlfwMHxvRiApKfZgmYLZpNPfIwxAqnbI7Vnv5mc_ie0VkkIwWSdAWtxbKQNzXcEc6DzuFHayyiy3weXB58rB9qQ-VT7NTdeCVpOsMMFaxw0Xu2S5hLf5RGguCsU7SoTCuCxXuXFFajwzqbNBChn2yEm7v3rSVNHQLBYnbQHRCIiOgOwR9RIFXc_dF6HpNaLFf-YetpDp-EFWenF89t8fPiJr_ZurS315PhwckHVcuPG4HJLlevrHfwYNUtsv8aD9A4s-2r4
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LT8MwDI5gCMQF8RSDATlwpKNpmnU5Itg0GJo4MAlOVdIkMIk9tJbDfgL_GnttYRNCHDhWqaM2buLP7mebkHNjhFDMCk8aX3mhksaTKhGe1mEzCa3G-oTItug1Ov3w7kmUbMK0oFWiD-3yQhHzsxo398S4khF3GXDOwGcXSMySdbDHAbhWq2RNyDBC_8t_7nyHWcC-g1Urc3d-k16ySks1S3-c0XPD094mWwVipFe5infIih3tkvW8h-Rsj3y0vup107GjgOfoQk4VnYwz5APBBPC6FDPGpm-Y2USHFnN-B-kwRbF0NrKgVliLC6oo8szHI5DDoa6CC1r-g4fhFzUATEmxCcsUzk06fR0gAyndJ_126_G64xX9FbyEM5F5YLUCq4VwzDQ5MwD0AiOxlVWoA-1M5GwkDSyPb31p_Ug1NYA1wRLltDaBCvgBqYzgaQ4JjXgig4bkLlEmjGSkTOIry5RvtBNcuCqpl-sbT_IyGjErqpOWColRIXGhkCqRi1qIs3n8wuXNRmL-h2ytVFlc7MgU7kQoyQBwHf1j6jOy8XDTju9ve91jsokjeTimRirZ9N2eAEDJ9On8E_wEDXLeXQ
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Evaluation+of+the+therapeutic+potential+and+underlying+mechanisms+of+synephrine%2C+a+component+of+Kampo+medicine%2C+against+allergic+rhinitis&rft.jtitle=Cogent+biology&rft.au=Hommura%2C+Tomoko&rft.au=Katsuaki+Dan&rft.au=Kanzaki%2C+Sho&rft.au=Watanabe%2C+Kenji&rft.date=2019-01-01&rft.pub=Taylor+%26+Francis+Ltd&rft.eissn=2331-2025&rft.volume=5&rft.issue=1&rft_id=info:doi/10.1080%2F23312025.2019.1592274
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2331-2025&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2331-2025&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2331-2025&client=summon